title: Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
authors.affiliation: Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.
authors.forename: Peter U
authors.initials: PU
authors.lastname: Fischer
authors.affiliation: Case Western Reserve University, Cleveland, Ohio, United States of America.
authors.forename: Christopher L
authors.initials: CL
authors.lastname: King
authors.affiliation: Bill and Melinda Gates Foundation, Seattle, Washington, United States of America.
authors.forename: Julie A
authors.initials: JA
authors.lastname: Jacobson
authors.affiliation: Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.
authors.forename: Gary J
authors.initials: GJ
authors.lastname: Weil
mesh_terms: D000349:Africa / Q000453:epidemiology; D015766:Albendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use*; D004049:Diethylcarbamazine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004605:Elephantiasis, Filarial / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage / Q000627:therapeutic use*; D009855:Onchocerciasis / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control
chemical_list: D000871:Anthelmintics; D007559:Ivermectin; D015766:Albendazole; D004049:Diethylcarbamazine